Evaluating health policy and legal responses : how to reduce barriers and improve access to orphan drugs for rare diseases in Canada
Abstract : Rare diseases are debilitating conditions often leading to severe clinical manifestations for affected patients. Orphan drugs have been developed to treat these rare diseases affecting a small number of individuals. Incentives in the legal framework aimed to recoup the research and develo...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
Université de Sherbrooke
2016
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/11143/9592 |